Loading…
ResMed Inc.
Technology · Surgical & Medical Instruments & Apparatus
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.6B | $4.2B | $4.7B | $5.1B |
| Gross Profit | $1.8B | $2.0B | $2.4B | $2.7B | $3.1B |
| Operating Income | $903.7M | $1.0B | $1.1B | $1.3B | $1.7B |
| Net Income |
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.
| $474.5M |
| $779.4M |
| $897.6M |
| $1.0B |
| $1.4B |
| Diluted EPS | $3.24 | $5.30 | $6.09 | $6.92 | $9.51 |
| Operating Cash Flow | $736.7M | $351.1M | $693.3M | $1.4B | $1.8B |
| Free Cash Flow | $634.0M | $216.3M | $573.6M | $1.3B | $1.7B |